Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 3, 2022
Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiencyLisa Göschl, Daniel Mrak, Katharina Grabmeier-Pfistershammer, et al.
Journal of Autoimmunity|January 27, 2023
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseasesDaniel Mrak, Felix Kartnig, Daniela Sieghart, et al.
Journal of Autoimmunity|October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitisLisa Göschl, Teresa Preglej, Patricia Hamminger, et al.
Wiener Klinische Wochenschrift|July 3, 2026
[Vaccination of immunocompromised individuals: Expert opinion - update 2026]Ursula Wiedermann, Angelika Wagner, Alexander Bartuschka, et al.
Annals of the Rheumatic Diseases|June 10, 2026
Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapyTeresa Preglej, Anela Tosevska, Marie Brinkmann, et al.
JCI Insight|February 28, 2020
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiationTeresa Preglej, Patricia Hamminger, Maik Luu, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|June 21, 2023
Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritisMaximilian Kugler, Mirjam Dellinger, Felix Kartnig, et al.
Clinical Immunology (Orlando, Fla.)|March 5, 2025
Autoantibody development is associated with clinical severity of COVID-19: A cohort studyMarie Brinkmann, Ludwig Traby, Manuel Kussmann, et al.
Pageof 3